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ABSTRACT To localize activated protein kinase C (PKC) in smooth muscle cells, an antibody directed to the catalytic site
of the enzyme was used to assess PKC distribution by immunofluorescence techniques in gastric smooth muscle cells
isolated from Bufo marinus. An antibody to vinculin was used to delineate the cell membrane. High-resolution three-
dimensional images of immunofluorescence were obtained from a series of images collected through focus with a digital
imaging microscope. Cells were untreated or treated with agents that increase PKC activity (10 M carbachol for 1 min, 1 M
phorbol 12-myristate 13-acetate (PMA) for 10 min), or have no effect on PKC activity (1 m 4- phorbol, 12,13-didecanoate
(4- PMA)). In unstimulated cells, activated PKC and vinculin were located and organized at the cell surface. Cell cytosol
labeling for activated PKC was sparse and diffuse and was absent for vinculin. After treatment with carbachol, which
stimulates contraction and PKC activity, in addition to the membrane localization, the activated PKC exhibited a pronounced
cytosolic fibrillar distribution and an increased total fluorescence intensity relative to vinculin. The distributions of activated
PKC observed after PMA but not 4- PMA were similar to those observed with carbachol. Our results indicate that in resting
cells there is a pool of activated PKC near the cell membrane, and that after stimulation activated PKC is no longer
membrane-confined, but is present throughout the cytosol. Active PKC appears to associate with contractile filaments,
supporting a possible role in modulation of contraction.
INTRODUCTION
Protein kinase C (PKC) is a central component in the
transduction pathway linked to phospholipid turnover in the
plasma membrane (Andrea and Walsh, 1992; Asuoka et al.,
1993; Haller et al., 1990; Langlands and Diamond, 1992;
Nishizuka, 1984). In smooth muscle PKC is considered to
play a significant role in mediating agonist-stimulated short-
term cellular responses associated with contraction and
changes in ionic distribution, as well as longer-term cellular
events such as cell growth, differentiation, and hypertrophy
(Andrea and Walsh, 1992; Asuoka et al., 1993; Nishizuka,
1984). Phosphorylation of specific target proteins by PKC
determines the pathways that are regulated by this kinase.
Those targets are, in turn, determined not only by substrate
specificity of this enzyme family, but also by substrate
accessibility to PKC, since its distribution is altered after
activation.
Cell fractionation methods provided some of the earliest
information regarding changes in the distribution of PKC,
revealing that stimuli that caused its activation appeared to
induce a shift in it’s distribution from a soluble “cytosolic”
fraction to a particulate, “membrane” fraction (Haller et al.,
1990; Langlands and Diamond, 1992). While these results
provided an easy explanation for why stimuli that activate
PKC also trigger phosphorylation of membrane proteins and
cause changes in numerous membrane-associated functions
in intact cells, they provided little aid in understanding why
these same stimuli also trigger phosphorylation of numerous
cytoskeletal/contractile proteins.
Investigators using standard, nonquantitative immunoflu-
orescence and imaging methods in intact cells have increas-
ingly reported PKC localizations to other subcellular struc-
tures such as focal contacts, cytoskeleton, and nuclei (e.g.,
Haller et al., 1994; Khalil et al., 1992; Khalil and Morgan,
1991; Liu et al., 1989; Mochly-Rosen, 1995; Mochly-Rosen
et al., 1990). Evidence has also accumulated to indicate the
existence of multiple isoforms of PKC that are classified in
subfamilies of similar genetic origin, structure, and regula-
tion (Andrea and Walsh, 1992; Asuoka et al., 1993; Hug and
Sarre, 1993; Morgan and Morgan, 1984). In addition, it is
clear that multiple isoforms of PKC are often co-expressed
in any given cell and that the various isoforms can regulate
different cellular processes (Haller et al., 1994; Khalil and
Morgan, 1992; Liu et al., 1989; Morgan and Morgan, 1984).
There is, therefore, increased interest in precisely establish-
ing the subcellular localization and possible translocation
for each of the PKCs associated with specific cellular
responses.
Studies utilizing fluorescent phorbol esters as well as
antibodies to PKC and its various isotypes have been uti-
lized in smooth muscle cells (Ali et al., 1994; Andrea and
Walsh, 1992; Assender et al., 1994; Donnelly et al., 1995;
Haller et al., 1994; Khalil et al., 1992; Khalil and Morgan,
1991, 1992; Schwartz, 1992). They have shown increased
staining of the surface membrane, perinuclear regions, and
nucleus that occurs within minutes following stimulation of
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cells with agonists expected to increase PKC activity (An-
drea and Walsh, 1992; Haller et al., 1994; Khalil et al.,
1992; Khalil and Morgan, 1991, 1992). The temporal rela-
tionships between these translocation events and the
changes in smooth muscle function that ensue after PKC
activation have not been completely resolved. For example,
it is noteworthy that many of the translocation events that
occur are complete within minutes. However, the contrac-
tion that occurs after PKC activation is typically slowly
developing and generally begins within 10 min but does not
reach a sustained maximum for 30 to 60 min (Andrea and
Walsh, 1992; Walsh et al., 1993). As one approach to
understanding the redistribution of PKC after activation, we
carried out studies first to further characterize an antibody
that preferentially binds to activated PKCs, and then to
utilize immunofluorescent labeling in conjunction with
high-resolution three-dimensional (3D) microscopic imag-
ing to analyze the distribution of activated PKC in single
isolated smooth muscle cells both at rest and after stimula-
tion with agonists expected to increase PKC activity.
METHODS
Specificity of the anti-PKC and preferential
binding to active PKC
A monoclonal anti-PKC antibody developed by Mochly-Rosen and Ko-
shland (1987, 1988) was chosen for these studies as prior observations
suggested that it might recognize an epitope on different PKCs that is
expressed only upon activation of PKC. In this previous work, Mochly-
Rosen and Koshland (1988) used a PKC activity assay to detect and
identify inhibitory antibodies that specifically inhibited activity of intact,
nondenatured, highly purified, rat brain PKCs. The properties of several
such antibodies were further investigated (Mochly-Rosen and Koshland,
1987, 1988), including the IgM designated MAb 1.9, which reportedly
displayed unique behavior in several assays. First, the MAb 1.9 directly
inhibited the activity of purified intact mixed PKC isoforms. Second, they
found that it also inhibited the unregulated constitutively active catalytic
domains of mixed PKC isoforms created by partial trypsin proteolysis. In
contrast, it had no effect (Mochly-Rosen and Koshland, 1987) on the
activity of the closely related cAMP-dependent protein kinase (Hanks and
Hunter, 1995; Nishizuka, 1992), indicating specificity for the PKC cata-
lytic domain. Third, they reported that the epitope recognized by MAb 1.9
also appears to be functionally linked to the catalytic domain, since ATP
binding to PKC diminished binding of MAb 1.9. Finally, a dependence of
MAb 1.9 binding to PKC when the enzyme is in an activated and/or
semi-denatured state was suggested by its complete lack of binding in
SDS-Page, but the retention of binding in immunofluorescence, immuno-
precipitation, and ELISA. Based on these findings, we reasoned that the
activated state would expose the catalytic epitope for MAb 1.9. We
therefore also performed several experiments to address this issue and
further test the properties of MAb 1.9 under conditions that activate PKCs
in vitro and in vivo.
PKCs from either rat brain protein extract or toad stomach protein
extract were immunoprecipitated with MAb 1.9. The immunoprecipitation
procedure was required because the anti-PKC IgM, MAb 1.9, is not useful
for Western blotting, as was previously reported (Mochly-Rosen and
Koshland, 1987). These experiments allowed us to determine whether
MAb 1.9 preferentially recognized activated PKC. This was accomplished
by mixing MAb 1.9 with varying concentrations of phorbol 12-myristate
13-acetate (PMA) (109-106 M), and phosphatidylserine (1 mg/ml) with
protein extracts containing PKC. To this mixture was added an anti-IgM
bound to Protein A Sepharose. After 1-h incubation followed by centrif-
ugation, the supernatant was removed and the Sepharose pellet rinsed with
a 20 mM Tris buffer. The rinsed pellet was then mixed with sample buffer
and boiled to free PKC from the antibodies. Identical volumes of sample
buffer were loaded on an SDS-PAGE gradient gel (9.5–16%). The gel was
blotted onto nitrocellulose (Western blot) and reacted with a rabbit poly-
clonal anti-pan-PKC (2 g/ml; Upstate Biotechnology Inc., 06-155) fol-
lowed by an HRP-labeled goat anti-rabbit IgG secondary (Jackson Immu-
noResearch). Labeled PKC was detected with an ECL chemiluminescent
system (Amersham Corporation). Bands on the developed film were quan-
titated on a Visage System (Kodak) and expressed as integrated optical
density.
In a second set of experiments, fresh tissue slices (200 M thick)
were made from toad stomach after removal of the mucosa. These tissue
slices were incubated in either amphibian Kreb’s Ringer (AKR) alone,
AKR containing 10 M carbachol for 1 min, AKR with 1 M PMA for 10
min, or AKR with 1 M 4- PMA for 10 min. Tissue slices were fixed
with paraformaldehyde and permeabilized with Triton X-100. Tissue se-
lections were cut into 1-mm2 sections, placed in 2 M sucrose on a mounting
peg, and frozen in liquid N2. Frozen pieces were cryosectioned (Reichert
Ultra Cut, FC4E) into 8–10-M-thick sections and were placed on a glass
slide and immunofluorescently labeled for PKC and vinculin as described
above. Images of sections were obtained using a confocal microscope
(Biorad MRC 600). Images were background-subtracted and total inte-
grated optical density was measured in a 100  100 pixel square. Fluo-
rescence was expressed as a ratio of PKC/vinculin fluorescence.
In a final set of experiments, colocalization of MAb 1.9 with a poly-
clonal pan-PKC antibody (Santa Cruz Biotechnology Inc., sc-77) was
assessed in PMA-stimulated tissue. In these studies, freshly isolated toad
stomachs were cut in cross-sections, equilibrated in oxygenated AKR,
exposed to 100 nM PMA in AKR for 30 s, then blotted and flash-frozen in
liquid N2-cooled isopentane. Cryosections (10 M) were then cut from
frozen cross-sectional pieces with a cryostat, and thawed in the presence of
4% paraformaldehyde in PBS at 4°C. Fixation was allowed to proceed for
10 min with warming to room temperature. Sections were then permeabil-
ized and immunolabeled as described above for cells, with the following
exceptions. First, sections were placed in blocking buffer (3% goat serum,
2% BSA, 0.05% Triton X-100, and 0.02% NaN3 in PBS, pH 7.4) in a
humidified chamber for 1 h to minimize nonspecific antibody binding.
Second, primary antibodies (MAb 1.9 at 50 g/ml, polyclonal pan-PKC at
1:100 dilution) were applied simultaneously in this blocking buffer. Third,
whole secondary antibodies were used, and included goat anti-mouse
IgM- (rhodamine-labeled, 1:100) and goat anti-rabbit IgG (HL, serum-
absorbed, fluorescein-labeled, 1:100). And finally, repeated final washes
with PBS were followed by mounting in 2% DABCO mounting media
mixed with 190-nM diameter broad-spectrum fluorescent latex beads for
use in image alignment.
Cell preparation and labeling
Smooth muscle cells were enzymatically isolated from the stomach of the
toad Bufo marinus as previously described (Fay et al., 1982). Isolated cells
were suspended in an amphibian physiological saline solution (AKR)
containing (in mM): NaCl (108.9), KCl (3.0), NaH2PO4  H2O (2.2),
MgSO4 (0.97), Na2HPO4  7H2O (0.55), NaHCO3 (200), and CaCl2 (1.8).
For immunocytochemistry, cells were allowed to settle for 60–90 min onto
poly-L-lysine-coated glass coverslips (0.5%) that had been acid and ethanol
washed. Before fixation, cells were exposed to either 10 M carbachol for
1 min, 1 M phorbol 12-myristate 13-acetate (PMA) for 10 min, or 1 M
4- phorbol 12,13-didecanoate (4- PMA, an inactive phorbol conjugate)
for 10 min, or were exposed only to AKR. Cells were then fixed by
immersion in 2% paraformaldehyde in phosphate-buffered saline (PBS) for
10 min (pH 7.4) containing (in mM): KCl (2.7), KH2PO4 (1.5), NaCl (137),
and Na2HPO4 (8.0), followed by washes in glycine buffer (0.1 M, pH 7.4)
to quench unreacted aldehyde. Fixed cells were permeabilized with 0.1%
Triton X-100 for 10 min followed by washes in PBS.
After rinsing, cells were labeled simultaneously with two primary
antibodies. Primary antibodies were 1) a mouse monoclonal IgG raised
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against chicken gizzard vinculin (100 g/ml; Sigma, VIN 11–5), which we
have previously reported recognized primarily a single band at 135 kDa in
unboiled toad stomach extracts on Western blots (unpublished observa-
tion), and 2) a mouse monoclonal IgM prepared against a highly purified
mixture of rat brain PKCs containing both particulate-extracted (active)
and cytosolic PKCs (Mochly-Rosen and Koshland, 1987, 1988), (40 M/
ml; GIBCO-BRL, MAb 1.9). Primary and secondary antibodies were
dissolved in a sodium citrate buffer containing (in mM): NaCl (300), Na3
citrate (30), 2% goat serum, 1% bovine serum albumin (BSA), 0.05%
Triton X-100, and 0.02% NaN3. All antibody incubations were from 60
min. Excess unbound antibody was removed with washes in PBS contain-
ing 0.1% Triton X-100.
Secondary antibody for anti-PKC was a goat anti-mouse IgM heavy
chain () specific Fab fragment that was labeled with fluorescein (Jackson
ImmunoResearch). Secondary antibody for anti-vinculin was a goat anti-
mouse IgG heavy chain () specific Fab fragment that was labeled with
Texas Red. Coverslips with labeled cells were mounted on glass slides with
9:1 glycerol/10 PBS and DABCO (1% w/v) mounting medium. In
addition, 190-nm beads with a broad fluorescent emission (510–665 nm;
Molecular Probes) where fluorescence could be recorded by both fluores-
cein and Texas Red Filter sets were mixed with the mounting medium to
act as fiduciary markers for alignment of images. To assess nonspecific
binding of secondary antibodies from specific binding to primary antibod-
ies, cells were labeled without permeabilization, or with each secondary
antibody alone. Autofluorescence was assessed in unlabeled cells. Also,
some cells were labeled with a nonspecific mouse IgM as the primary
antibody.
3D microscopy
Images of labeled cells were acquired with a Zeiss IM-35 microscope
equipped with a 100 W mercury arc lamp for epifluorescence microscopy.
Cells were viewed with a 60 Nikon (NA 1.4) planapo objective and 16
eyepiece, and images were captured by a Photometrics thermoelectrically
cooled CCD camera (RCA 501 chip). A PC was used to control a stepper
motor attached to the fine focus and the position of the objective relative
to the stage was monitored with an eddy-current sensor. Additionally, a
controlled shutter regulated the duration of illumination (Fay et al., 1989).
Digitized images of labeled cells were obtained at 0.25 m intervals. This
through-focus image series was transferred to Silicon Graphics worksta-
tions for analysis. In addition, a through-focus set of images was acquired
of fluorescent beads 190 nm in diameter. The beads were labeled with
fluorescein, rhodamine, and Texas Red and provided an empirical measure
of the microscope point spread function under optical conditions identical
to those in which images from labeled cells were acquired.
Image restoration and analysis
To prepare images for analysis, the dark-current and background were
subtracted from and the result was then flat-field corrected for nonunifor-
mities in illumination intensity and camera sensitivity across the field of
view. Three-dimensional data sets were processed using a constrained
deconvolution algorithm based on regularization theory (Carrington, 1990;
Carrington et al., 1990; Fay et al., 1989) to reverse blurring introduced by
microscope optics. Image pairs were aligned using the fiduciary markers,
and to eliminate nonspecific signal, restored images were thresholded using
an intensity value that eliminated 99% of the signal detected in restored
images of cells labeled with secondary antibody alone.
To find the surface of the cells we defined a function that corresponded
to a cylinder that was positioned around the outside of the cell, but not
touching it. The outline of the cylinder was allowed to deform to points of
maximum fluorescent intensity on the cell surface (Moore et al., 1993;
Lifshitz, 1998). Cell surface coordinates obtained in this fashion were used
to define a cell boundary zone that was 0.45 m on either side of the
identified cell edge. To further improve identification of point sources of
fluorescence, data within the boundary annulus were convolved with the
image of a restored 190-nm fluorescent bead (analogous to using a matched
filter). Points in the convolved image that were local maxima in z (i.e.,
vertical optical axis) were identified as the true position of structures which
remained partially blurred after restoration due to poorer resolution along
the vertical axis of the microscope. The resulting one-voxel annulus (150
nm3/voxel) was defined as the vinculin-localized cell surface (Moore et al.,
1993; Lifshitz, 1998).
Fig. 1 illustrates the processes of image restoration, segmentation, and
FIGURE 1 Demonstration of im-
age restoration, segmentation, and
cell surface localization. A fixed cell
is shown labeled with anti-vinculin
IgG and an anti-mouse secondary an-
tibody conjugated to Texas Red. The
data set for this cell contained 42 2D
image planes, of which 20 are dis-
played before and after restoration in
the bisected cell image on the left.
Images on the right were obtained by
rotating the 3D cell image by 90°
about the y axis and segmenting the
data set to display 450-nm-thick sec-
tions along the x-z axes. To improve
the definition of the surface of cells
from anti-vinculin images, the image
of the cell was convolved with the
image of a restored fluorescent bead
to identify fluorescent points of max-
imum intensity.
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cell surface localization used to analyze the distribution of PKC and
vinculin at near-membrane sites. The cell depicted in this figure was
labeled with an anti-vinculin IgG and an anti-mouse Fab fragment conju-
gated with rhodamine. The full data set for this cell contained 42 image
planes acquired at 0.25-m intervals. To avoid superimposition of front
and back surfaces, the cell is shown bisected in the x, y plane, and 20 planes
of data in z are displayed before and after restoration. Cross-sections, 0.45
m thick, are also displayed before and after restoration. Approximately
90% of total vinculin fluorescence was located at the cell surface within a
150-nm-wide annulus.
Fluorescein anti-PKC signal was considered to colocalize with Texas
Red anti-vinculin signal if it had the same x and y coordinates and had a z
coordinate that was no more than 1 voxel (150 nm) away from the maxima.
Colocalization was constrained so that only one voxel with signal specific
for PKC could colocalize with only one voxel with signal specific for
vinculin. Criteria for colocalization in z were relaxed as previously de-
scribed by this laboratory, to allow for more limited resolution along the z
axis and corresponding uncertainty in defining the true z position (Moore
et al., 1993; Lifshitz, 1998). Cell boundary coordinates were used to define
the distribution of PKC-specific fluorescence as a function of distance from
the cell membrane and fluorescent intensity per voxel.
RESULTS
Anti-PKC specificity and preferential binding to
active PKC
Experiments were carried out to determine whether MAb
1.9 preferentially identified activated PKC over the nonac-
tivated kinase. Figs. 2 and 3 show the results of an exper-
iment to determine whether the binding of MAb 1.9 to PKC
is enhanced by its activation, as would be expected if
epitope exposure is activation-dependent. Specifically, pro-
tein kinase C in protein extracts from both rat brain (Fig. 2)
and toad stomach (Fig. 3) were activated by increasing
levels of PMA (109-106 M) and the ability of MAb 1.9 to
immunoprecipitate PKC was determined. Immunoprecipi-
tated PKC was run on a Western blot and identified and
quantified using a polyclonal anti-pan-PKC, which primar-
ily detected a band at 97 kDa. We found that MAb
1.9-mediated immunoprecipitation of PKC was increased in
a dose-dependent fashion by PMA pretreatment of the re-
action mixture for both rat brain protein extract (Fig. 2) and
toad stomach protein extract (Fig. 3). The effect of PMA
was specific for the predominant 97-kDa band identified as
PKC with the polyclonal antibody. Toad stomach PKC was
therefore clearly recognized by this antibody, and this rec-
ognition dramatically increased with application of very low
doses of PMA, which are known to activate PKC. While the
extent of binding of PKC to MAb 1.9 increased after expo-
sure of tissue to PMA in extracts from both rat brain and
toad stomach, the shape of the concentration-response rela-
tionships differed between the rat brain and toad stomach.
The precise reason for this difference is unclear. It may well
reflect differences between these preparations in the extent
of proteolysis, the presence of endogenous activators, or
presence of different PKC isoforms between rat and toad,
leading to differences in the fraction of PKC molecules that
are active in the absence of PMA. It is clear, however, that
the extent of binding was enhanced in the presence of 1 M
PMA, which was the concentration of PMA utilized for the
immunolabeling experiments.
To examine whether anti-PKC IgM had retained its spec-
ificity for the activated form of PKCs after fixation under
conditions required for the immunolocalizing experiments,
we studied the effect of activation on immunolabeling effi-
ciency in toad stomach. This was accomplished using fresh
tissue slices of toad stomach (200 m thick) that were
then incubated with AKR alone or with added PMA, 4-
PMA, or carbachol. These thin slices were then fixed and
immunofluorescently labeled for PKC and vinculin, and
measurements of total PKC-specific and vinculin-specific
fluorescence obtained from confocal images. A ratio of
PKC/vinculin fluorescence is presented in Fig. 3. We found
that after treatment with PMA and carbachol, but not 4-
PMA, the fluorescence ratio was significantly increased by
150% and 227%, respectively (Fig. 3), demonstrating en-
hanced binding of the anti-PKC antibody. The ratio of PKC
FIGURE 2 Demonstration of immunoselectivity of anti-PKC IgM (MAb
1.9) for the active form of PKC in rat brain cell lysate. Top: Immunopre-
cipitation of PKC from rat brain with the MAb 1.9. First and last lanes
show rat brain protein extract run for comparison without immunoprecipi-
tation. From left to right, lanes 2–6 show amount of immunoprecipitated
PKC after addition of increasing concentrations of PMA. Lane 7 was a
buffer-only blank (B). Bottom: Optical density measurements of the blot.
Relative optical density of the bands corresponding to PKC in lanes 2–6
are plotted versus the PMA concentration. Effects of PMA on band density
were consistently confined to the band identified as PKC.
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to vinculin fluorescence corrects for variability in the num-
ber of cells in a given microscopic field and nonspecific
variations in labeling efficiency. These results indicate
that the anti-PKC IgM MAb 1.9 epitope was preserved in
fixed tissue and again demonstrated activation-dependent
accessibility.
Finally, to directly test whether MAb 1.9 was PKC-
specific in this tissue, we compared MAb 1.9 colocalization
with a pan-PKC antibody after PMA stimulation. As shown
in Fig. 4, a highly significant (nonrandom) colocalization
for dual labeling with MAb 1.9 and pan-PKC antibody was
found. MAb 1.9 colocalization with anti-pan-PKC averaged
55.9  13.9% (mean  SD), a level of colocalization very
close to that observed when two antibodies are used to
recognize the same epitope in this tissue. The fact that the
maximum level of colocalization that can be achieved is
100% reflects 1) small residual errors in registration of
image pairs where these pairs are aligned to the nearest
pixel (Moore et al., 1993); and 2) an area of a small but
finite probability that the antibody fails to find or stay bound
to its epitope (Mochly-Rosen and Koshland, 1988).
Distribution of activated PKC in smooth muscle:
restored images
Restored images of a cell at rest and a carbachol-treated cell
labeled for activated PKC and vinculin are shown in Fig. 5.
From restored images of the resting cell, it can be seen that
active PKC (left-hand panels) is distributed in an annular
manner near the cell membrane defined by the distribution
of vinculin (right-hand panels). Specific labeling is appar-
ent in top and bottom surface views, but is noticeably absent
in sections through the cell center. Active PKC, like vincu-
lin, is not diffusely distributed but appears organized as
strands which are oriented along the cell’s long axis and are
nearly parallel. The bands are spaced 0.5 m apart. No
specific labeling was detected in nonpermeabilized cells or
cells treated with the secondary antibody alone.
After treatment of cells with carbachol (bottom panels),
the distribution of active PKC was significantly changed so
that activated PKC-specific label was now clearly apparent
throughout the interior of the cell. The pattern of distribu-
tion within the cytosolic region was very filamentous and
FIGURE 3 Demonstrations of immunoselectivity of anti-PKC IgM (MAb 1.9) for the active form of PKC toad stomach cell lysate. Top left:
Immunoprecipitation of PKC from toad stomach with MAb 1.9 IgM used for immunofluorescent localization of PKC. The first lane shows toad stomach
protein extract run for comparison, without immunoprecipitation. The second lane was a buffer-only blank (B). From left to right, lanes 3–7 show amount
of immunoprecipitated PKC after addition of increasing concentrations of PMA. The band position corresponding to the reported molecular weight for PKC
is 97 kDa. Bottom left: Optical density measurements of the blot shown at top left. Relative optical density of bands corresponding to PKC in lanes 3–7
are plotted versus concentration of PMA in the immunoprecipitation reaction mixture. Dose-dependent changes in optical density were confined to the band
identified as PKC. Bottom right: Quantitation of binding of MAb 1.9 to thin slices of toad stomach tissue after stimulation with carbachol (10 m for 1
min) or PMA (1 m for 10 min). Average fluorescence intensity per pixel with MAb 1.9 was normalized with anti-vinculin labeling in the same field to
correct for differences in amount of tissue between sections.
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remarkably similar to previously reported distribution pat-
terns observed for calponin, actin, and tropomyosin (Walsh
et al., 1993). There was no visible activated PKC labeling in
the nuclear region. Carbachol had no evident effect on the
distribution pattern of vinculin. Treatment of smooth mus-
cle cells with PMA, but not 4- PMA (Fig. 6), produced a
change in distribution that was similar to that seen with
carbachol. Activated PKC was visibly organized in fila-
ment-like strands through the cytosol but not in the nuclear
region. Vinculin distribution was also unaffected by PMA.
In Fig. 7, the cells were rotated 90° about their x axis to
display cross-sections. Each cross-section displayed is 150
nm thick and represents a cross-sectional view taken from
the cell region indicated by arrows in the margins of Figs. 5
and 6. Cross-sectional images have been pseudocolored to
display PKC as green and vinculin as red, and images have
been superimposed. If voxels are green they contain only
activated PKC, if they are red they contain only vinculin, if
they are white they contain both vinculin and activated
PKC, and if they are black they contain neither protein.
Cross-sectional views clearly show the increase in activated
PKC within the cytosol. To facilitate visualization of
changes in activated PKC distribution in a larger portion of
the smooth muscle cell, a control cell and a carbachol-
treated cell are shown as stereo image pairs in Fig. 8. Stereo
pairs clearly illustrate the annular distribution of vinculin in
red overlying a subsurface pool of activated PKC in green.
Furthermore, the distribution of the activated PKC appears
to mirror the distribution of the vinculin, but to be offset
from it toward the interior of the cell. The increase in
activated PKC labeling within the cell center is readily
apparent in the carbachol-treated cell.
Quantitative analysis of 3D fluorescence images
The distribution of activated PKC in resting toad stomach
smooth muscle cells was subjected to extensive analysis in
reference to the vinculin label, a marker for the cell mem-
brane. Quantitative analysis of overlap between activated
PKC and vinculin indicated that in the unstimulated cell
40.8% of activated PKC-specific signal was within the 150
nm annular region defined by vinculin label. Of this annular
activated PKC, 17.9% of the voxels containing activated
PKC also contained vinculin. These vinculin-containing
voxels represented only 10.8% of total vinculin (Table 1).
Colocalization of these two proteins was significantly less
than could be accounted for by chance alone. Remaining
activated PKC at the membrane (82%) resided in non-
vinculin-containing regions of the cell surface, most likely
the caveolar domain of the membrane. Experiments in non-
permeabilized cells showed no specific immunolabeling
with MAb 1.9 indicating that the PKC label in non-vinculin-
containing areas did not represent a nonspecific caveolar
uptake of the antibody. Beyond the 150-nm membrane
annulus, and extending to 300 nm, the remaining 59.2% of
the activated PKC-specific fluorescent signal was found to
be primarily located in regions under the vinculin-rich areas
located at the cell membrane. The subvinculin location of
this pool of activated PKC was made readily apparent by
projecting the distribution of this pool of activated PKC to
the surface membrane below the vinculin in a radial direc-
tion to the depth of 300 nm. Analysis of these projection
images indicated that 80% of activated PKC located
within 300 nm of the surface mapped to within 150 nm of
vinculin-containing voxels, a numerical confirmation of the
FIGURE 4 MAb 1.9 and pan-PKC antibodies label
the same structures in toad gastric smooth muscle after
100 nM PMA stimulation (30 s). The end panels above
depict the distribution of MAb 1.9 (A) and Santa Cruz
polyclonal pan-PKC (C) in the smooth muscle layer of
a 10 m section of PMA-stimulated, flash-frozen toad
stomach (60 objective, 5 eyepiece). The images
shown are opaque 3D projections of fluorescence inten-
sity in a 1-m-thick subsection (four z planes) of
smooth muscle after image restoration, image alignment
with fiduciary marker beads, and detection of z axis
maxima as described in the text. Processing of these
images included quantification of nonspecific fluores-
cence in noncellular regions and background subtraction
to remove 99% of this fluorescence. The center panel
(B) depicts the two datasets projected together, with
colocalizing voxels shown in white and no relaxation of
z axis colocalization requirements as for cell analysis.
Calculation of colocalization statistics for 62 1-m3
areas randomly chosen from muscle cell areas indicates
that the probability of this degree of colocalization being
due to chance is p  0.000058 (versus random and
independent placement of the same number of voxels
found in the two images).
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visual impression given by the stereo pairs (Fig. 8) is
presented in Fig. 9. Compared to control cells, colocaliza-
tion of membrane-localized activated PKC with vinculin
was 12.3% (significantly lower than control, p 0.05) after
PMA, 22.0% after carbachol (not statistically different from
control, p  0.05), and was 15.0% after 4- PMA (not
statistically different from control, p  0.05) (Table 1).
Analysis of activated PKC in cytosol
Numerical analysis of the distribution of activated PKC-
specific fluorescence as a function of distance from the cell
surface confirmed the change in activated PKC distribution
(Fig. 9). In unstimulated control cells, activated PKC was
most concentrated in an annular region 300 nm inside the
vinculin-defined cell surface, as indicated by the peak flu-
orescent distribution. Treatment of cells with PMA or carba-
chol, but not 4- PMA, significantly altered distribution of
fluorescence such that the density of activated PKC-specific
labeling further from the cell membrane had increased. Acti-
vated PKC labeling was distributed throughout the interior of
the cell, no longer confined to a region close to the cell surface.
DISCUSSION
In resting smooth muscle cells, our data indicated that most
activated PKC is located 300 nm beneath the cell surface
and is structurally organized into strands that are oriented
roughly parallel to one another along the cell’s long axis.
This same pattern of organization was observed at the cell
surface with vinculin. Ultrastructurally, smooth muscle has
been shown to possess a uniquely organized membrane
associated with electron-dense material reflecting zones of
cell attachment (Gabella and Blondell, 1978). These bands
were described as running along the cell’s long axis and
exhibiting branches and occasional interconnections. Elec-
FIGURE 5 Immunofluorescent images of stomach
smooth muscle cells dual-labeled for PKC (left) and
vinculin (right). Cell images displayed at the top are for
unstimulated resting cell; images displayed at the bottom
are for a cell treated with carbachol (10 M for 1 min).
Images show the distribution of PKC and vinculin dis-
played as three 750-nm-thick sections in an x-y projec-
tion. Sections displayed represent the top (T), center (C),
and bottom (B) views of the cell. Arrows at the left-hand
cell margin indicate the location from which the cross-
sectional views shown in Fig. 7 were obtained.
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tron-dense bands were interspersed with bands of cell mem-
brane containing caveolae. Thus, the membrane was defined
as containing two structural domains, a cell attachment
domain and a caveolar domain. In addition, interband spac-
ing was 0.35–0.40 m, which is similar to the interband
spacing of 0.5 m that we observed. Collectively, these
observations suggest that surface and subcellular molecular
organization are related.
To examine whether activated PKC and vinculin were
distributed in a coordinated manner, we analyzed the spatial
relationship between fluorescent labels for activated PKC
and vinculin. From this analysis we determined that in
resting smooth muscle, 41% of total activated PKC-spe-
cific signal was at the membrane (i.e., at or within 150 nm)
and only 18% of this PKC was specifically colocalized with
vinculin. Thus, most of the activated PKC at the membrane
was distributed to non-vinculin-containing membrane re-
gions such as the caveolar domain. The caveolar domain of
the membrane is thought to play a central role in membrane
Ca2 handling (Rasmussen et al., 1987). It is potentially
relevant that the sarcoplasmic reticulum often approaches to
within 20 nm of individual caveolae (Gabella and Blondell,
1978). Moreover, previous work from this laboratory has
established that within this functional domain of the mem-
brane there is a close positional relationship between Na/K
ATPase and the Na/Ca2 exchanger (Moore et al., 1993).
Thus, the activated PKC near this region may be related to
modulation of membrane ion exchange processes such as its
postulated role in the regulation of Ca2 handling by the
plasma membrane and sarcoplasmic reticulum (Andrea and
Walsh, 1992; Hug and Sarre, 1993; Nishizuka, 1984).
In the resting, unstimulated cells the presence, and re-
striction, of activated PKC near the membrane might be
related to the existence of high calcium concentration near
and under the membrane. In toad smooth muscle cells,
measurement of near-membrane [Ca2] was accomplished
FIGURE 6 Distribution of PKC and vinculin in two
single smooth muscle cells after one treatment with 4-
PMA (1 M for 10 min) and PMA (1 M for 10 min).
Organization and conventions used in this figure are
identical to those described for Fig. 5.
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using Ca2 indicators that localize to the membrane or
near-membrane space, such as FFP18 and C18-Fura-2 (Et-
ter et al., 1994, 1996). Measurement of calcium with these
dyes suggest that [Ca2] changes near the membrane are
large and occur more rapidly than in the bulk cytoplasmic
space. Similarly, in the rat aortic smooth muscle cell line
A7r5, a membrane-targeting aequorin derivate, indicated
that Ca2 concentration in the cytoplasmic space beneath
the plasma membrane increases to a greater degree after cell
stimulation and is higher in unstimulated cells than in the
bulk cytosol (Marsault et al., 1997). Thus, the presence of
an elevated Ca2 concentration in the near-membrane cy-
toplasmic space may, in part, explain the pool of activated
PKC near the membrane.
A caveolar localization for membrane PKC has been
reported by several different laboratories (e.g., Smart et al.,
1995; Oku et al., 1997; Mineo et al., 1998). Our interpre-
tation of a caveolar distribution for the membrane pool of
activated PKC is consistent with these reports. The accu-
mulation and targeting of active PKC in the caveolae ap-
pears to involve a docking mechanism associated with bind-
ing proteins located within the caveolae, such as caveolin
(Oku et al., 1997; Mineo et al., 1998).
In unstimulated cells the remaining pool of activated
PKC was 59% of total activated PKC-specific signal and
was located between 150 nm and 300 nm from the mem-
brane. This pool of PKC exhibited a distribution pattern that
was similar to the surface distribution pattern of vinculin, as
indicated by the fact that the pattern of activated PKC
distribution when projected to the surface mapped to re-
gions containing vinculin to a high degree. This indicated
that submembrane activated PKC was located beneath vin-
culin-rich regions in the plasma membrane. This suggested
a close structural relationship between vinculin, PKC, and
perhaps other proteins associated with the contractile fila-
ments or their anchoring to the membrane (Schwartz, 1992;
Turner and Burridge, 1991). A PKC labeling pattern resem-
bling vinculin has also been described for rat embryo fibro-
blasts (Jaken et al., 1989). Vinculin is known to be but one
protein among several involved in anchoring contractile
filaments to integrins within the plasma membrane (Luna
and Hitt, 1992; Turner and Burridge, 1991; Turner et al.,
1989). Other proteins include vimentin, -actinin, f-actin,
paxillin, zyxin, tensin, and talin (Luna and Hitt, 1992;
Turner and Burridge, 1991; Turner et al., 1989). A recent
and potentially relevant study reported that Rack1, a recep-
tor for activated PKC, binds to the  subunit of integrins
(Liliental and Chung, 1998). This could provide an expla-
nation for the accumulation of PKC in this region. In recent
unpublished observations by D. Schmidt (personal commu-
nication), Rack1, PKC, and vinculin were all shown to
exhibit similar overlapping distribution patterns in toad
smooth muscle cells.
Our observations of PKC localization near vinculin are
consistent with other studies that have shown that PKC medi-
ated phosphorylation of proteins associated with the cell mem-
brane anchorage complex. Phosphorylation of these proteins
may be important in regulation of adhesion (Turner et al.,
1989). Furthermore, the presence of activated PKC in the
region of the contractile filaments may lead to phosphorylation
of one or more of the proteins involved in contractile filament
interaction and thus could be important in mediating Ca2-
independent contractions in smooth muscle (Andrea and
Walsh, 1992; Bradley and Morgan, 1987; Collins et al., 1992;
Himpens et al., 1988; Moore et al., 1993; Hanks and Hunter,
1995; Rembold and Murphy, 1988; Stull et al., 1991). One
difficulty with the concept that PKC is associated with con-
tractile filament function was the early view that activated
PKC is only localized to the plasma membrane. This view
grew out of studies in which cell fractionation techniques have
been used to separate PKC activity into a particulate (or mem-
brane) pool and a cytosolic pool (Haller et al., 1990; Langlands
and Diamond, 1992). In our study, after stimulation with either
carbachol or phorbol esters, activated PKC was found to be
located not only at the cell membrane, but also within the cell
FIGURE 7 Relative distribution of PKC and vinculin in cross-sections
of single smooth muscle cells in the presence or absence of agents expected
to stimulate PKC activity. Cross-sectional segments of smooth muscle cells
are shown for control and carbachol-treated cells displayed in Fig. 4 and for
4- PMA (1 M for 10 min) and PMA-treated (1 M for 10 min) cells
displayed in Fig. 5. These 150-nm-thick segments are a representation of
the cells rotated by 90° in the y axis. Sections displayed were obtained from
cells shown in Figs. 5 and 6 at the locations indicated by marginal arrows.
In these sections, voxels have been pseudocolored to display PKC as green,
vinculin as red, and superimposed voxels containing both PKC and vin-
culin as white. Black voxels contain neither.
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center. This cytosolic PKCwas found to exhibit a filament-like
distribution pattern in the smooth muscle cells. Thus, our
observations provide support for the putative role of PKC in
regulating membrane ion transport functions and contractile
protein function.
While the view that upon activation PKC becomes asso-
ciated with filamentous elements most likely involved in
contraction appears to run contrary to views based on cell
fractionation studies, other recent immunocytochemical
studies have revealed somewhat similar results. Specifically
in cardiac muscle and in cultured vascular smooth muscle
(Haller et al., 1994; Liu et al., 1989; Mochly-Rosen et al.,
1990), an increase in anti-PKC immunofluorescence asso-
ciated with filaments has been observed after stimulation of
PKC with either contractile agonists or phorbol esters. The
specific PKC isozyme detected in the studies on cardiomy-
ocytes was not well-defined, but was suggested to be the 
isoform (Mochly-Rosen et al., 1990); in contrast, the iso-
form that appeared transiently on filaments in stimulated
cultured vascular smooth muscle cell was the  isoform
(Haller et al., 1994). The monoclonal antibody (MAb 1.9)
used in our studies recognizes an epitope that may be
present on more than one PKC isoform after activation.
Thus, the results obtained in our study may reflect the
distribution of more than one isoform. Further studies will
be required with more specific problems to determine the
distribution of individual PKC isoforms.
It is unlikely that all of the many isoforms of PKC that
have been reported for smooth muscle (Ali et al., 1994;
Andrea and Walsh, 1992; Assender et al., 1994; Donnelly et
al., 1995; Haller et al., 1994; Khalil et al., 1992; Khalil and
Morgan, 1992; Singer et al., 1992) are recognized by MAb
1.9 or are appearing on contractile filaments after stimula-
tion. In general, the pattern of distribution of antibody
FIGURE 8 Stereo pairs of distribu-
tion of anti-PKC (MAb 1.9) and anti-
vinculin staining in two smooth mus-
cle cells, one stimulated with
carbachol (1 M for 1 min) (bottom)
and the other untreated (top). The
arrow in the carbachol images points
to an open space devoid of PKC that
contained the nucleus. Images are
pseudocolored to display PKC-con-
taining voxels as green, vinculin-con-
taining voxels as red, and voxels con-
taining both PKC and vinculin as
white.
TABLE 1 Characteristics of activated PKC distribution in single smooth muscle cells
Control PMA Carbachol 4- PMA
Percent total signal at membrane
Vinculin 89.0  6.0 (5) 91.9  3.0 (4) 89.5  5.5 (4) 96.2  1.80 (3)
Activated PKC 40.8  7.6 (5) 24.5  4.3 (4) 24.9  3.5 (4) 36.8  10.5 (3)
Colocalization of membrane-associated PKC and vinculin
Vinculin with activated PKC 10.8 4.1* 4.7  3.5 10.6  4.6* 8.4  1.6*
Activated PKC with vinculin 17.9 3.4* 12.3  2.8# 22.0  3.8* 15.0  5.2*
The top of the table presents the fraction of total fluorescence intensity specific for vinculin and protein kinase C (PKC) that was located at the cell
membrane; the bottom presents an analysis of the extent of colocalization of vinculin and activated PKC at the cell membrane. The first row presents the
fraction of voxels containing vinculin that also contained activated PKC, while the second row presents the fraction of voxels containing activated PKC
that also contained vinculin. Numbers in parentheses represent the number of cells analyzed.
*Observed overlap between the two proteins was less (p 95%) than would have been predicted if the two proteins were randomly distributed with respect
to each other. Predicted overlap was generated from a random distribution whose variance was (Np) (1-p), where N was total number of voxels on the
membrane, and p was the probability that a voxel contained both proteins.
#Significantly different from control.
982 Biophysical Journal Volume 77 August 1999
staining for different PKC isoforms, both at rest and after
stimulation, is quite isoform-specific in smooth muscle
(Haller et al., 1994; Khalil et al., 1992; Khalil and Morgan;
1992) as well as in other cells (Hug and Sarre, 1993; Liu et
al., 1989; Nishizuka, 1984). Ongoing work is therefore
focused on determining which PKC isoform is being de-
tected on the filaments after cell stimulation.
In our study, the increase in overall smooth muscle cell
fluorescence after activation is interpreted as an increase in
the total pool of activated PKC. This interpretation is con-
sistent with findings of the immunoprecipitation experi-
ments. Because the anti-PKC antibody used for immunola-
beling prefers the active form of PKC, the change in
distribution of activated PKC that we observed may not
necessarily reflect a translocation event. Instead, activation
of the kinase appears to improve access of the antibody to
its PKC binding epitope. The presence of PKC within the
cytosolic compartment after activation contrasts signifi-
cantly with the view that activation involves strict translo-
cation of activated PKC to the outer cell membrane (Asuoka
et al., 1993; Nishizuka, 1984). The filament-like distribution
of activated PKC within the cell center is consistent with
functional studies showing that PKC could have access to and
consequently have effects on the contractile mechanism.
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FIGURE 9 Radial distribution patterns of anti-PKC (MAb 1.9) and anti-vinculin staining density for control cells (n  5) and cells treated with PMA
(1 M for 10 min) (n 4), carbachol (10 M for 1 min) (n 4), or 4- PMA (1 M for 10 min) (n 3). The histogram display shows average fluorescence
intensity normalized for volume by expressing it as average fluorescent intensity per voxel as a function of distance from the cell surface for vinculin (solid
line) and PKC (dashed line). The left y axis for PKC or vinculin was normalized to 1 with respect to vinculin, the right y axis shows the absolute values
for the fluorescent intensities per voxel for each of the proteins.
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